Orin Hirschman, Director at NeuBase Therapeutics, holds 1.64M shares in NeuBase Therapeutics (Ticker: NBSE), holds 381.50K shares in Lightpath Technologies (Ticker: LPTH), holds 0.00 shares in 8X8 (Ticker: EGHT). Most recently, Orin Hirschman Bought ― shares of NeuBase Therapeutics on Apr 13, 2017 for an estimated value of 100.00K.